Biological Therapy Industry in Asia Countries: Market Research Reports, Statistics and Analysis

Company Report: Cell Therapy In Japan For Year 2012

... Of the immuno-cell therapy market in order to maximize revenue of its core service, immuno-cell therapy total support service. As a part of such business activities, medinet group has implemented intensive ...

Company Report: Cell Therapy In India And Israel For Year 2012

... Focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (v) uresidential ...

Company Report: Biological Therapy In China For Year 2013

Company Report: Biological Therapy In Japan For Year 2012

... Drug for lysosomal storage diseases, licensed to glaxosmithkline group, was started. As a result, despite the nhi price reduction effected in april, the sales of core products, growject and epoetin ...

Company Report: Biological Therapy In China For Year 2013

Merck Kgaa - Company Report For Year 2012

Company Report: Stem Cell In Malaysia For Year 2012

... Timeframe mentioned. The stem cell specialist. 10 B 10. Borrowings and debt secutirities as at the current period under review, the group does not have any borrowings ...

Cell Culture In Japan And France : Innovation And Technology Tren ...

... The ministry of health labour and welfare is taking the lead in establishing domestic production and supply of pandemic influenza vaccine using cell- culture technology, Which is expected to shorten ...

Biological Therapy In Japan : Innovation And Technology Trends

... Ps (induced pluripotent stem) cells, which are pluripotent like es (embryonic stem) cells, from skin cells of mice. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures ...